Europe Multiple Sclerosis Market and Competitive Landscape - 2017

  • ID: 4377591
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Multiple Sclerosis Market and Competitive Landscape - 2017, provides comprehensive insights into Multiple Sclerosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Multiple Sclerosis market size and drug sales. This research also provides insights into Multiple Sclerosis epidemiology and late stage pipeline.

The report is classified into nine sections - Multiple Sclerosis overview with definitions, symptoms, etiology, diagnosis, treatment options; Multiple Sclerosis pipeline insights covering late stage clinical trials pipeline; Multiple Sclerosis prevalence trends by countries; Multiple Sclerosis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Multiple Sclerosis pipeline: Find out the drugs in clinical trials for Multiple Sclerosis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Multiple Sclerosis epidemiology: Find out the prevalence of Multiple Sclerosis by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Multiple Sclerosis products: Identify key products marketed and prescribed for Multiple Sclerosis by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Sclerosis market size: Find out the market size for Multiple Sclerosis drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Multiple Sclerosis drug sales: Find out the sales of Multiple Sclerosis drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Multiple Sclerosis drugs sales forecast: Sales forecast for Multiple Sclerosis drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Multiple Sclerosis market share analysis: Find out the market shares of Multiple Sclerosis drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Multiple Sclerosis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Multiple Sclerosis market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Multiple Sclerosis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Multiple Sclerosis: Disease Overview
1.1. Multiple Sclerosis Symptoms
1.2. Multiple Sclerosis Etiology
1.3. Multiple Sclerosis Diagnosis
1.4. Multiple Sclerosis Treatment Options

2. Multiple Sclerosis Pipeline Insights
2.1. Multiple Sclerosis Phase 3 Clinical Trials
2.2. Multiple Sclerosis Phase 2 Clinical Trials
2.3. Multiple Sclerosis Phase 1 Clinical Trials

3. Multiple Sclerosis Epidemiology Analysis

4. Germany Multiple Sclerosis Market Insights
4.1. Marketed Products for Multiple Sclerosis in Germany
4.2. Germany Multiple Sclerosis Market Size & Forecast
4.3. Germany Multiple Sclerosis Product Sales Forecast
4.4. Germany Multiple Sclerosis Market Share Analysis

5. France Multiple Sclerosis Market Insights
5.1. Marketed Products for Multiple Sclerosis in France
5.2. France Multiple Sclerosis Market Size & Forecast
5.3. France Multiple Sclerosis Product Sales Forecast
5.4. France Multiple Sclerosis Market Share Analysis

6. Italy Multiple Sclerosis Market Insights
6.1. Marketed Products for Multiple Sclerosis in Italy
6.2. Italy Multiple Sclerosis Market Size & Forecast
6.3. Italy Multiple Sclerosis Product Sales Forecast
6.4. Italy Multiple Sclerosis Market Share Analysis

7. Spain Multiple Sclerosis Market Insights
7.1. Marketed Products for Multiple Sclerosis in Spain
7.2. Spain Multiple Sclerosis Market Size & Forecast
7.3. Spain Multiple Sclerosis Product Sales Forecast
7.4. Spain Multiple Sclerosis Market Share Analysis

8. UK Multiple Sclerosis Market Insights
8.1. Marketed Products for Multiple Sclerosis in UK
8.2. UK Multiple Sclerosis Market Size & Forecast
8.3. UK Multiple Sclerosis Product Sales Forecast
8.4. UK Multiple Sclerosis Market Share Analysis

9. Europe Multiple Sclerosis Market Insights
9.1. Europe Multiple Sclerosis Market Size & Forecast
9.2. Europe Multiple Sclerosis Product Sales Forecast
9.3. Europe Multiple Sclerosis Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Multiple Sclerosis Phase 3 Clinical Trials, Global, 2017
Table 2: Multiple Sclerosis Phase 2 Clinical Trials, Global, 2017
Table 3: Multiple Sclerosis Phase 1 Clinical Trials, Global, 2017
Table 4: Multiple Sclerosis Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Multiple Sclerosis in Germany, 2017
Table 6: Germany Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 8: Germany Multiple Sclerosis Market Trends, 2012 - 2021
Table 9: Marketed Products for Multiple Sclerosis in France, 2017
Table 10: France Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 12: France Multiple Sclerosis Market Trends, 2012 - 2021
Table 13: Marketed Products for Multiple Sclerosis in Italy, 2017
Table 14: Italy Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 16: Italy Multiple Sclerosis Market Trends, 2012 - 2021
Table 17: Marketed Products for Multiple Sclerosis in Spain, 2017
Table 18: Spain Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 20: Spain Multiple Sclerosis Market Trends, 2012 - 2021
Table 21: Marketed Products for Multiple Sclerosis in UK, 2017
Table 22: UK Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Table 24: UK Multiple Sclerosis Market Trends, 2012 - 2021
Table 25: Europe Multiple Sclerosis Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Multiple Sclerosis Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Multiple Sclerosis Pipeline by Phase (%), Global, 2017
Figure 2: Multiple Sclerosis Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 4: Germany Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 5: Germany Multiple Sclerosis Market Share by Products (%), 2016
Figure 6: Germany Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 7: France Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 8: France Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 9: France Multiple Sclerosis Market Share by Products (%), 2016
Figure 10: France Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 11: Italy Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 12: Italy Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 13: Italy Multiple Sclerosis Market Share by Products (%), 2016
Figure 14: Italy Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 15: Spain Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 16: Spain Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 17: Spain Multiple Sclerosis Market Share by Products (%), 2016
Figure 18: Spain Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 19: UK Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 20: UK Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 21: UK Multiple Sclerosis Market Share by Products (%), 2016
Figure 22: UK Multiple Sclerosis Market - Future Market Share (%), 2021
Figure 23: Europe Multiple Sclerosis Market Size ($mn), 2012 - 2021
Figure 24: Europe Multiple Sclerosis Product Sales ($mn), 2012 - 2021
Figure 25: Europe Multiple Sclerosis Market Share by Products (%), 2016
Figure 26: Europe Multiple Sclerosis Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll